Background
Cytomegalovirus (CMV) shedding among CMV-seropositive women living with HIV (WLHIV) on antiretroviral therapy (ART)—and its impact on infant CMV infection in non-breastfeeding settings—remains unclear. We aimed to assess maternal CMV shedding in urine from pregnancy through six weeks postpartum, determining the timing and incidence of infant CMV transmission through 12 months of age. Potential impacts of CMV infection on infant growth and neurodevelopment were explored.
Methods
A total of 150 CMV-seropositive pregnant WLHIV receiving ART and 132 of their non-breastfed infants were prospectively enrolled in a cohort study in Brazil. Participants were selected based on the availability of stored maternal (1st, 2nd, 3rd trimesters, delivery, and 6 weeks postpartum) and infant (birth, 3, 6, and 12 months) urine samples. CMV-DNA was quantified using real-time PCR. Incidence of maternal and infant viral shedding and its correlates were analyzed. Logistic regression models were used to explore predictors of maternal and infant CMV shedding.
Results
CMV shedding was detected in 29 of 150 women (19.3%; 95%CI: 13.0%–25.6%). The median CMV DNA concentration in urine was 2.44 log₁₀ copies/mL. CMV shedding was strongly associated with recreational drug use in pregnancy (Adjusted Odds Ratio, aOR >6) and lymphocyte CD4 T-cell counts <350 cells/mm³ at study entry (aOR >8). No association was found between the timing of sample collection and CMV-DNAuria levels. Among 132 infants, 5 (4.1%; 95%CI: 1.3%–9.3%) had congenital CMV infection (confirmed: n=3; presumed: n=2), and 12 (10.3%; 95%CI: 5.4%–17.2%) had perinatal or postnatal (Pe/Pn) CMV infection. Correlates for cCMV were maternal viral shedding and household crowding (>2people per room), and low (<350 cells/mm3) maternal CD4+ counts for Pe/Pn CMV. CMV status was not associated with neurodevelopmental risk. A possible relationship between stunting at 12 months of age and Pe/Pn CMV infection was found.
Conclusions
These findings shed light on the relatively frequent occurrence of cytomegalovirus shedding in urine during gestation among women living with HIV, particularly in recreational drug users and those with immunosuppression during pregnancy. The facilitation of congenital CMV by maternal immunosuppression and household crowding, and the occurrence of later postnatal infections in non-breastfed infants, underscore the relevance of controlling immunosuppression and addressing environmental factors in this population to prevent CMV infections.